Regarding “Endovascular repair of para-anastomotic aortic aneurysms”  by Scurr, James R.H. et al.
But why is neointimal hyperplasia a relatively asymptomatic
condition if compared with equal-grade atherosclerotic stenosis?
The answer may be the lower embolic potential and, to ascertain
this issue, we compared clinic and instrumental findings in these
groups of patients. Five patients (4 men, 1 woman; mean age, 72
years) with asymptomatic type IV ISR (70% stenosis, developed
6 months from the procedure) and 10 patients (7 men, 3
women; mean age, 74 years) with asymptomatic severe atheroscle-
rotic plaque (70% stenosis) underwent follow-up visits every 3
months for a year. During each visit, clinical assessment and
transcranial Doppler monitoring for emboli detection were per-
formed. A 2-MHz multichannel transcranial Doppler Multidop
X-4 device (DWL, Sipplingen, Germany) was used in all patients
for 1-hour insonation of the middle cerebral artery, bilaterally. The
parameters were chosen according to the recommendations of the
International Consensus Group on Microembolus detection, and
microembolic signals (MES) were identified according to current
guidelines.3
All patients with ISR were asymptomatic and showed no MES
during follow-up. The stenosis degree was stable during follow-up,
and no revascularization procedure was performed. Among 10
patients with severe atherosclerotic plaque, two have had an ipsi-
lateral carotid transient ischemic attack at 6 months of follow-up.
They both showed MES and were immediately revascularized
without periprocedural complications; a further two patients re-
mained asymptomatic but showed MES at 9 months and were
successfully revascularized. In all these patients, MES were de-
tected in the middle cerebral artery ipsilateral to the stenotic
carotid artery but not in the contralateral one.
These results suggest that ISR, generally attributed to neoin-
timal hyperplasia, is associated with a low embolic load and then
with a low risk of cerebrovascular complications. As for asymptom-
atic carotid stenosis due to atherosclerosis, instead, the risk of
cerebrovascular events seems related to the presence of MES as
surrogate markers of plaque destabilization.4-6 Thus transcranial
Doppler monitoring for emboli detection may be a powerful tool
to select high-risk patients for early revascularization procedure.
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Reply
Thank you for your interest in our article relating patterns of
in-stent restenosis (ISR) after carotid artery stenting (CAS) to
long-term outcomes.1 As stated by you, the key finding was that
the type of ISR and diabetes were independent predictors of future
high-grade ISR necessitating revascularization after CAS.
We agree with you that neointimal hyperplasia is associated
with a reduced potential for atheroembolization. As you have
observed, our results support this view. All our patients developed
high-grade ISR early during the course of their follow-up (24
months), which was likely due to neointimal hyperplasia. None of
these patients presented with atheroembolic neurologic complica-
tions. The reason for reintervening on these patients was the
preocclusive nature of the lesions and the inability of any testing
modality to predict which of these lesions would proceed to carotid
occlusion with subsequent stroke.
Risk stratification by measuring embolic signals with transcra-
nial Doppler has been intensively analyzed with conflicting results
till date. Studies have demonstrated a strong correlation with risk
for future stroke2 and, conversely, no correlation with risk for
subsequent stroke.3 A consensus has still not been reached on the
clinical utility or accuracy of this approach.4 The overarching
theme of all these studies, however, was that TCD was hypothe-
sized to be of utility in primary atherosclerotic carotid stenosis and
not in recently recurrent carotid stenosis that is likely the result of
neointimal hyperplasia. We appreciate the results of your study,
which confirm that intimal hyperplastic lesions carry a low poten-
tial for embolization. It is less likely that TCD will find utility in risk
stratification for the treatment of in-stent restenosis.
The current study1 was undertaken as an attempt to predict
which low-grade recurrent stenoses will progress to high-grade
lesions. Our results indicate that diffuse proliferative (type IV) ISR
lesions and diabetes are important and independent predictors of
progression and reintervention.
Thank you.
Brajesh K. Lal, MD
UMDNJ-New Jersey Medical School
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Regarding “Endovascular repair of para-anastomotic
aortic aneurysms”
Sachdev et al reported their experience of endovascular repair of
para-anastomotic aortic aneurysms (PAAA).1 We note that they state
that “Predictors of type I endoleaks include short, angulated aortic
necks, which are characteristic of proximal para-anastomotic aneu-
rysms of the infrarenal aorta” after open repair. Such infrarenal neck
anatomy can be inadequate to achieve a proximal seal with a standard
infrarenal device. Transrenal device fixation used in a short neck does
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not increase the seal zone length and did not prevent a type 1
endoleak in two of the patients treated in their series.1
Although the durability of endovascular repair for PAAA is
unknown, the early benefits are clear in this high-risk group of
patents. Customized fenestrated and branched stent grafts that will
preserve flow to essential visceral arteries now allow proximal seal
and fixation to be achieved at and above the renal level. This
endovascular treatment option was not discussed by Sachdev et al
but can, and should now be considered for the treatment of
juxta-renal PAAA.2-5
We accept that in symptomatic patients there may not be the
time to refer, plan, and manufacture these advanced stent grafts. In
addition, the need for precise alignment/deployment can be tech-
nically more difficult when working within the reduced space of a
previous surgical graft.3,5
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Reply
Branched grafts may be particularly useful in the treatment of
para-anastomotic aneurysms of the infrarenal aorta, which are charac-
terized by short necks.1 However, as is mentioned in the letter, the
time required to refer the patients to centers that are currently per-
forming these procedures, as well as to manufacture the appropriate,
custom-made devices, may prohibit expeditious repairs in patients
who are symptomatic or ill. Furthermore, side branch technology,
which is required for true pararenal and thoracoabdominal lesions,
remains in the early stages of development.
The marked variability of the visceral artery takeoff from the
aorta, combined with the frequently present occlusive disease in
the visceral artery origins and throughout the artery, makes deploy-
ment as well as maintenance of patency challenging. None of the
patients treated in this series had aneurysmal disease involving the
origin of the renal arteries.
Although transrenal fixation does not necessarily increase the
seal zone of endovascular stent grafts, it does allow for anchorage
of the device in a segment of aorta that is usually spared from
significant dilation.2,3 Our study demonstrates that devices that
offer transrenal fixation may be adequate for treating aneurysms
involving the proximal anastomosis of an infrarenal aortic graft.4
The letter writers correctly point out that proximal type 1 en-
doleaks developed in two of our patients after they were treated with
devices offering transrenal fixation for proximal para-anastomotic
aneurysms of the infrarenal aorta. However, 15 other patients treated
with transrenal fixation for para-anastomotic aneurysms in the same
location did not develop proximal type 1 endoleaks during a mean
follow-up period of 20.7 months (range, 0.8-76.6 months).4 Al-
though the use of branched and fenestrated grafts in patients with
para-anastomotic aneurysms may be extremely useful in select pa-
tients, commercially available devices may exclude many of these
aneurysms with satisfactory results, allowing for earlier time to repair
in a greater number of centers.
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